FDA Asks Opana ER Maker to Pull Drug from Market (FREE)

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH
The FDA has asked the maker of Opana ER — an extended-release version of oxymorphone — to remove the drug from the market because " the benefits of the drug may no longer outweigh its risks. " In …

Source: Physician's First Watch current issue - June 12, 2017 Category: Primary Care Source Type: news